Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Home - |
Description | Immunotherapy. Skip to footer Histogen About Us Our Science Investors Contact Immunotherapy. Redefined. Who we are Managed by highly successful biotech industry veterans |
Keywords | N/A |
WebSite | histogeninc.com |
Host IP | 15.197.142.173 |
Location | United States |
Site | Rank |
US$1,274
Last updated: 2023-05-13 12:40:50
histogeninc.com has Semrush global rank of 0. histogeninc.com has an estimated worth of US$ 1,274, based on its estimated Ads revenue. histogeninc.com receives approximately 147 unique visitors each day. Its web server is located in United States, with IP address 15.197.142.173. According to SiteAdvisor, histogeninc.com is safe to visit. |
Purchase/Sale Value | US$1,274 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$35 |
Yearly Ads Revenue | US$423 |
Daily Unique Visitors | 9 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
histogeninc.com. | A | 599 | IP: 15.197.142.173 |
histogeninc.com. | A | 599 | IP: 3.33.152.147 |
histogeninc.com. | NS | 3600 | NS Record: ns54.domaincontrol.com. |
histogeninc.com. | NS | 3600 | NS Record: NS53.domaincontrol.com. |
histogeninc.com. | MX | 1800 | MX Record: 20 histogen-com.inbound.emailservice.cc. |
histogeninc.com. | MX | 1800 | MX Record: 30 histogen-com.inbound.emailservice.co. |
histogeninc.com. | MX | 1800 | MX Record: 10 histogen-com.inbound.emailservice.io. |
histogeninc.com. | TXT | 600 | TXT Record: MS=ms74845169 |
histogeninc.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
Skip to footer Histogen About Us Our Science Investors Contact Immunotherapy. Redefined. Who we are Managed by highly successful biotech industry veterans, Histogen is a drug development company initially focused on treating infectious diseases by restoring the competence of the human body’s immune system to effectively combat these infections. Histogen is doing this by developing potential first-in-class clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that help restore the body’s natural immune processes that are being attacked by invading organisms. Our product candidates include emricasan, CTS-2090, and other proprietary caspase inhibitors. Currently, we are developing emricasan for acute bacterial skin and skin structure infections (ABSSSI) as well evaluating its use for other infectious diseases. Our pipeline also includes novel preclinical product candidates including CTS-2090 which are highly selective small molecule inhibitors of caspase-1 |
HTTP/1.1 405 Not Allowed Server: awselb/2.0 Date: Tue, 21 Dec 2021 10:29:31 GMT Content-Length: 0 Connection: keep-alive WAFRule: HTTPMethodNOTAllowed |
Domain Name: HISTOGENINC.COM Registry Domain ID: 1143538009_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-08-10T17:54:09Z Creation Date: 2007-08-09T20:27:16Z Registry Expiry Date: 2023-08-09T20:27:16Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS53.DOMAINCONTROL.COM Name Server: NS54.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T08:36:34Z <<< |